ProShares Nanotechnology ETF Insiders
| TINY Etf | USD 46.68 0.69 1.46% |
Break down of ProShares Nanotechnology's management performance can provide insight into the ETF performance.
ProShares |
| Symbol | TINY |
| Name | ProShares Nanotechnology ETF |
| Type | Etf |
| Country | United States |
| Exchange | NYSE ARCA |
Information on ProShares Nanotechnology ETF Leadership is currently not available.
If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Thematic Opportunities
Explore Investment Opportunities
ProShares Nanotechnology Management Team Effectiveness
The company has return on total asset (ROA) of (0.03) % which means that it has lost $0.03 on every $100 spent on assets. This is way below average. ProShares Nanotechnology's management efficiency ratios could be used to measure how well ProShares Nanotechnology manages its routine affairs as well as how well it operates its assets and liabilities.ProShares Nanotechnology Workforce Comparison
ProShares Nanotechnology ETF is presently regarded as number one ETF in number of employees as compared to similar ETFs. The total workforce of Technology category is currently estimated at about 1,777. ProShares Nanotechnology adds roughly 7.0 in number of employees claiming only tiny portion of equities under Technology ETF category.
The company has Profit Margin (PM) of (22.08) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (263.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $263.42. ProShares Nanotechnology Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ProShares Nanotechnology insiders, such as employees or executives, is commonly permitted as long as it does not rely on ProShares Nanotechnology's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ProShares Nanotechnology insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Rendino Kevin over two months ago Acquisition by Rendino Kevin of 18098 shares of ProShares Nanotechnology at 1.7396 subject to Rule 16b-3 | ||
Wolfe Daniel B over three months ago Disposition of 3465 shares by Wolfe Daniel B of ProShares Nanotechnology at 2.75 subject to Rule 16b-3 | ||
Jamison Douglas W over six months ago Acquisition by Jamison Douglas W of 1000 shares of ProShares Nanotechnology at 2.444 subject to Rule 16b-3 | ||
Phillip Bauman over six months ago Acquisition by Phillip Bauman of 1960 shares of ProShares Nanotechnology at 2.8595 subject to Rule 16b-3 |
About ProShares Nanotechnology Management Performance
The success or failure of an entity such as ProShares Nanotechnology often depends on how effective the management is. ProShares Nanotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ProShares management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ProShares management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
The index consists of companies focused on making or applying nanotechnology innovations that allow for improved products, processes, or techniques through control or measurement of material at nanoscale. Proshares Nanotechnology is traded on NYSEARCA Exchange in the United States.
The data published in ProShares Nanotechnology's official financial statements typically reflect ProShares Nanotechnology's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving ProShares Nanotechnology's quantitative information. For example, before you start analyzing numbers published by ProShares accountants, it's essential to understand ProShares Nanotechnology's liquidity, profitability, and earnings quality within the context of the ProShares space in which it operates.
Please note, the imprecision that can be found in ProShares Nanotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of ProShares Nanotechnology ETF. Check ProShares Nanotechnology's Beneish M Score to see the likelihood of ProShares Nanotechnology's management manipulating its earnings.
When determining whether ProShares Nanotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProShares Nanotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Proshares Nanotechnology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Proshares Nanotechnology Etf: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ProShares Nanotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Nanotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.